http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108785309-A
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_304cec87147368a04b581d0fda05878c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5025 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 |
| filingDate | 2018-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_66b9ccd5f754e4e6919e62fecbb16af4 |
| publicationDate | 2018-11-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-108785309-A |
| titleOfInvention | Application of compound in preparation of medicine for treating chronic lung disease |
| abstract | The invention discloses the use of a compound in the preparation of a medicament for treating chronic lung disease. The compound has the following structure: The pharmaceutical composition has the functions of improving the function of lung tissue, promoting the phagocytosis of immune cells, increasing the vibration of tracheal and bronchial epithelial cilia, and dilating bronchial smooth muscle. Pharmacologically, it inhibits the increase of IL-6 in the alveoli, causes the accumulation of airway inflammatory cells, reduces chemotaxis, and can reduce the total number of white blood cells in the alveoli, the absolute number and percentage of neutrophils, thereby inhibiting the acute onset and exacerbation of chronic lung diseases. |
| priorityDate | 2018-04-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 17.